Clinical trial in Post-COVID
Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Long-COVID
https://clinicaltrials.gov/ct2/show/NCT05497089?term=temelimab&draw=2&rank=1
The GNC-501 study, entitled “Temelimab as a Disease Modifying Therapy in Patients with Neurological, Neuropsychological, and Psychiatric Symptoms in Post-COVID-19 or Post-Acute Sequelae of COVID-19 (PASC) Syndrome”, has enrolled 203 patients from Swiss and EU study centres suffering from severe neuropsychiatric syndromes following COVID infection. The biomarker-based study has enrolled only patients who are also tested positive for the pathogenic protein W-ENV, with the objective to reduce their invalidating conditions.
This trial is now fully recruited and results are planned for June 2024.
Current active sites:
SWITZERLAND
Geneva: Hôpital Universitaire de Genève – https://recherche.hug.ch/etudes/temelimab
Service de Premier Recours, Rue Gabrielle-Perret-Gentil 4, 1205 Genève.
Email: etude.longcovid@hcuge.ch
Basel: REHAB Basel Klinik für Neurorehabilitation und Paraplegiologie
Im Burgfelderhof 40, 4055 Basel
https://www.rehab.ch/en/medical-services/special-skills/post-covid-sprechstunde
Bern: INSELSPITAL, Neuroimmunological Study Centre (NIS)
Freiburgstrasse 14, SH2, EG3, 3010 Bern – http://www.NIS.insel.ch/
Chur: Kantonsspital Graubünden – https://www.ksgr.ch/long-covid-sprechstunde.aspx
Tel. +41 81 256 72 10
Sion: Hôpital du Valais– Centre hospitalier du Valais Romand –
Hôpital de Sion, Avenue du Grand-Champsec 80, 1950 Sion – Service de pneumologie
https://www.hopitalvs.ch/covid-long – https://www.hopitalvs.ch/pneumo – Marlène Salamin: +41 27 603 45 57
ITALY
Modena: Azienda Ospedaliero-Universitaria di Modena
Clinica Malattie Infettive – Prof. Giovanni Guaraldi
Via del Pozzo 71, 41124 Modena – Tel +39-0594222799 – Email clinica.metabolica@gmail.com; nb.protocolli@unimore.it
Rome: U.O.C. Malattie Infettive Tor Vergata, Policlinico Tor Vergata
Contact: Loredana Sarmati, MD, Prf
Tel. +39-06.2090.3440 – email: malattie.infettive@ptvonline.postecert.it
Rome: AMBULATORIO POST COVID-19, Palazzina CEMI
Fondazione Policlinico A. Gemelli IRCCS, Largo F. Vito 1 – 00168 Roma
Contact: +39 06 3015 1 –email: ambulatoriopostcovid@policlinicogemelli.it
Vipiteno/Sterzing: Ospedale di Vipiteno – Neuroriabilitazione / Krankenhaus Sterzing – Neurorehabilitation
Via S. Margherita, 24 / Margarethen-Straße 24, I-39049 Vipiteno/Sterzing (BZ)
Tel.: 0472 774 111 – https://home.asdaa.it/it/ospedali/vipiteno/Neuroriabilitazione.asp
SPAIN
Barcelona: Ace Alzheimer Center (FUNDACIO ACE), Barcelona
C/ Gran Via de Carles III, 85 bis, 08028 Barcelona, Spain
Contact: Mercé Boada Rovira, MD
AssaigsClinics assaigsclinics.ace@fundacioace.org – +34 93 444 73 18
Madrid: Blue Healthcare
Av. de Alberto de Alcocer, 5, y 7, 28036 Madrid
Tel: 91 999 17 70
Madrid: Hospital Universitario Quirónsalud Madrid
Diego de Velázquez, 1. 28223 Pozuelo de Alarcón, Madrid
Contact: Dr Pablo Guisado Vasco – email: pablo.guisado@quironsalud.es
+34 91 452 1900
Valencia: Fundación Hospital General Universitario de Valencia
Avda. Tres Cruces, 2 (acceso B3, 4ª planta) – 46014 Valencia
Tel.: +34-963 131 800 – email: fundacion_hgv@gva.es. medicinainterna_hgv@gva.es
https://fihgu.general-valencia.san.gva.es/quienes-somos/localizacion
https://chguv.san.gva.es/servicios-salud/servicios-unidades/medicina-interna
Zaragoza: Hospital Royo Villanova. Avd San Gregorio s/n 50015 Zaragoza
email: cpcovid@salud.aragon.es
Tel: +34-976466910 Ext 567066